Vergleich

Recombinant Human PD-L1/B7-H1/CD274 Protein (His Tag)

ArtNr ELS-PKSH033557-10ug
Hersteller Elabscience
Menge 10 ug
Quantity options 10 ug 50 ug
Kategorie
Typ Proteins
Format Lyophilized Powder
Applikationen ELISA
Specific against Human (Homo sapiens)
Host HEK293 cells
Konjugat/Tag HIS
Purity > 95 % as determined by reducing SDS-PAGE.
Sequence Phe19-Thr239
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias B7 Homolog 1, B7-H1, B7H1, CD274, PD-L1, PDCD1 Ligand 1, PDCD1L1, PDCD1LG1, PDL1, Programmed Cell Death 1 Ligand 1, Programmed Death Ligand 1
Similar products CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1, PD-L1, B7-H1, Programmed Cell Death 1 Ligand 1, PDCD1 Ligand 1, Programmed Death Ligand 1, B7 Homolog 1
Versandbedingung Gekühlt
Lieferbar
Manufacturer - Category
Recombinant Proteins / Immune Checkpoint Proteins
Manufacturer - Conjugate / Tag
C-His
Shipping Temperature
This product is provided as lyophilized powder which is shipped with ice packs.
Storage Conditions
Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Calculated Molecular Weight
26.3 kDa
Observed Molecular Weight
34-42 kDa
Research Areas
Cancer, immunology
Background
CD274; also known as B7-H1 or programmed death ligand 1 (PD-L1); is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. Programmed death-1 ligand-1 (PD-L1; CD274; B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. By binding to PD1 on activated T-cells and B-cells; PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly; it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.
Abbreviation
PD-L1; B7-H1; CD274
Endotoxin
< 1.0 EU per μg of the protein as determined by the LAL method.
Reconstitution
Please refer to the printed manual for detailed information.
Formulation
Lyophilized from a 0.2 μm filtered solution of 20mM PB, 4% Mannitol, 0.02% Tween 80, pH7.4.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Activity
Immobilized Anti-Human PDL1 mAb at 2μg/ml (100 μl/well)can bind Human PD-L1-His.The ED50 of Human PD-L1-6His is 5.57 ng/ml.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 10 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?